Equities

Vivimed Labs Ltd

VIVIMEDLAB:NSI

Vivimed Labs Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)4.95
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta1.1925
Data delayed at least 15 minutes, as of Jul 31 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2023202320222021
OPERATIONS
Net income(3307)(643)(758)
Depreciation/depletion1,084183529
Non-Cash items359398539
Cash taxes paid, supplemental00(251)
Cash interest paid, supplemental359398539
Changes in working capital2,1173385,337
Total cash from operations2542755,673
INVESTING
Capital expenditures--(164)--
Other investing and cash flow items, total5004,040
Total cash from investing50(164)4,040
FINANCING
Financing cash flow items(359)(398)(539)
Total cash dividends paid00--
Issuance (retirement) of stock, net00(3252)
Issuance (retirement) of debt, net21294(6362)
Total cash from financing(338)(104)(10153)
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash(34)7.53(441)
Net cash-begin balance/reserved for future use7264505
Net cash-end balance/reserved for future use387264
SUPPLEMENTAL INCOME
Depreciation, supplemental1,084183529
Cash interest paid, supplemental359398539
Cash taxes paid, supplemental00(251)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.